Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Limited Number of Anti-Idiotypic Antibodies Is Required To Maintain FVIII Function in Presence of Polyclonal Anti-FVIII Antibodies of Haemophilia A Patients with Inhibitors.

Jean Guy G. Gilles, PhD, Sabrina E. Grailly, MSc, Marc G. Jacquemin, MD, Jean Marie M. Saint-Remy, MD

Blood (2006) 108 (11): 1004.

https://doi.org/10.1182/blood.V108.11.1004.1004

Published: 2006

Journal Articles

In vivo neutralization of a C2 domain–specific human anti–Factor VIII inhibitor by an anti-idiotypic antibody

Jean Guy G. Gilles, Sabrina C. Grailly, Marc De Maeyer, Marc G. Jacquemin, Luc P. VanderElst, Jean-Marie R. Saint-Remy

Blood (2004) 103 (7): 2617–2623.

https://doi.org/10.1182/blood-2003-07-2207

Published: 2004

Journal Articles

A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor

Marc Jacquemin, Renaud Lavend'homme, Abdellah Benhida, Beatrijs Vanzieleghem, Roseline d'Oiron, Jean-Maurice Lavergne, Hans H. Brackmann, Rainer Schwaab, Thierry VandenDriessche, Marinee K. L. Chuah, Marc Hoylaerts, Jean Guy G. Gilles, Kathelijne Peerlinck, Jos Vermylen, Jean-Marie R. Saint-Remy

Blood (2000) 96 (3): 958–965.

https://doi.org/10.1182/blood.V96.3.958

Published: 2000

Journal Articles

Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A

Kathelijne Peerlinck, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson, Kathleen Freson, Dorothea Scandella, Jean-Marie R. Saint-Remy, Jos Vermylen

Blood (1999) 93 (7): 2267–2273.

https://doi.org/10.1182/blood.V93.7.2267

Published: 1999

Journal Articles

Mechanism and Kinetics of Factor VIII Inactivation: Study With an IgG4 Monoclonal Antibody Derived From a Hemophilia A Patient With Inhibitor

Marc G. Jacquemin, Benoı̂t G. Desqueper, Abdellah Benhida, Luc Vander Elst, Marc F. Hoylaerts, Marleen Bakkus, Kris Thielemans, Jef Arnout, Kathelijne Peerlinck, Jean Guy G. Gilles, Jos Vermylen, Jean-Marie R. Saint-Remy

Blood (1998) 92 (2): 496–506.

https://doi.org/10.1182/blood.V92.2.496

Published: 1998

NARROW

A Limited Number of Anti-Idiotypic Antibodies Is Required To Maintain FVIII Function in Presence of Polyclonal Anti-FVIII Antibodies of Haemophilia A Patients with Inhibitors.

In vivo neutralization of a C2 domain–specific human anti–Factor VIII inhibitor by an anti-idiotypic antibody

A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor

Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A

Mechanism and Kinetics of Factor VIII Inactivation: Study With an IgG4 Monoclonal Antibody Derived From a Hemophilia A Patient With Inhibitor

Email alerts

ASH Publications

American Society of Hematology

A Limited Number of Anti-Idiotypic Antibodies Is Required To Maintain FVIII Function in Presence of Polyclonal Anti-FVIII Antibodies of Haemophilia A Patients with Inhibitors.

In vivo neutralization of a C2 domain–specific human anti–Factor VIII inhibitor by an anti-idiotypic antibody

A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor

Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A

Mechanism and Kinetics of Factor VIII Inactivation: Study With an IgG4 Monoclonal Antibody Derived From a Hemophilia A Patient With Inhibitor

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only